Edition:
India

Orgenesis Reports 73 Percent Increase In Revenue For Q2

July 17 (Reuters) - Orgenesis Inc ::ORGENESIS REPORTS 73% INCREASE IN REVENUE FOR THE SECOND QUARTER OF FISCAL 2018.Q2 LOSS PER SHARE $0.20.Q2 REVENUE ROSE 73 PERCENT TO $4.0 MILLION.

8:22pm IST

Braster Signs Exclusive Distributorship Agreement With Pharmasco

July 17 (Reuters) - BRASTER SA ::SIGNS EXCLUSIVE DISTRIBUTORSHIP AGREEMENT WITH PHARMASCO LTD FOR SALE AND DISTRIBUTION OF CO'S DEVICES IN UKRAINE.UNDER DEAL PHARMASCO ALSO TO BE RESPONSIBLE FOR MARKETING AND PUBLIC RELATIONS FOR THE DEVICE AFTER CONSULTATIONS WITH COMPANY.DEAL IS FOR 3 YEARS FROM...

7:59pm IST

Pulmatrix Announces Positive Top-Line Preliminary Results From Part 3 Of The 3-Part Phase 1/1B Clinical Trial Of Pulmazole

July 17 (Reuters) - Pulmatrix Inc ::PULMATRIX ANNOUNCES POSITIVE TOP-LINE PRELIMINARY RESULTS FROM PART 3 OF THE 3-PART PHASE 1/1B CLINICAL TRIAL OF PULMAZOLE - AN INHALED DRY-POWDER ISPERSE™ FORMULATION OF ITRACONAZOLE.ALL OBJECTIVES FROM PART 3 SUCCESSFULLY MET.WITH PHASE 1/1B RESULTS FROM PART 3...

6:30pm IST

Silence Therapeutics Says Appoints David Horn Solomon As CEO

July 17 (Reuters) - Silence Therapeutics PLC ::APPOINTS DAVID HORN SOLOMON AS CEO.DAVID WILL HEAD LEADERSHIP TEAM AND JOINS BOARD OF DIRECTORS.SAYS APPOINTMENT OF SOLOMON EFFECTIVE IMMEDIATELY.APPOINTMENT OF DAVID HORN SOLOMON AS ITS NEW CHIEF EXECUTIVE OFFICER (CEO) EFFECTIVE IMMEDIATELY.

5:30pm IST

Expansion & New Markets

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.